Alembic Pharmaceuticals
Alembic Pharmaceuticals Performance
Day Range
- Low 763.45
- High 777.75
52 Week Range
- Low 462.30
- High 839.00
- Open Price775.00
- Previous Close773.60
- Volume28997
Start SIP in Alembic Pharmaceuticals
Start SIPAlembic Pharmaceuticals Investment Rating
-
Master Rating:
-
Alembic Pharmaceuticals has an operating revenue of Rs. 5,996.55 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 7% is okay, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 1,479 | 1,332 | 1,307 | 1,310 | 1,354 | 1,160 | 1,304 |
Operating Expenses Qtr Cr | 1,271 | 1,167 | 1,138 | 1,086 | 1,109 | 1,034 | 1,013 |
Operating Profit Qtr Cr | 207 | 166 | 169 | 224 | 245 | 127 | 291 |
Depreciation Qtr Cr | 67 | 66 | 74 | 66 | 67 | 46 | 46 |
Interest Qtr Cr | 15 | 14 | 14 | 15 | 12 | 9 | 6 |
Tax Qtr Cr | 0 | 0 | -47 | 25 | 21 | 0 | 0 |
Net Profit Qtr Cr | 134 | 98 | 131 | 119 | 146 | 72 | 251 |
Alembic Pharmaceuticals Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹748.93
- 50 Day
- ₹748.94
- 100 Day
- ₹731.49
- 200 Day
- ₹695.23
- 20 Day
- ₹743.20
- 50 Day
- ₹756.31
- 100 Day
- ₹756.88
- 200 Day
- ₹655.17
Alembic Pharmaceuticals Resistance and Support
Resistance | |
---|---|
First Resistance | 791.35 |
Second Resistance | 809.10 |
Third Resistance | 822.25 |
RSI | 62.56 |
MFI | 87.81 |
MACD Single Line | -1.53 |
MACD | 4.15 |
Support | |
---|---|
First Resistance | 760.45 |
Second Resistance | 747.30 |
Third Resistance | 729.55 |
Alembic Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 193,291 | 5,686,621 | 29.42 |
Week | 169,120 | 6,829,066 | 40.38 |
1 Month | 367,552 | 7,509,091 | 20.43 |
6 Month | 275,607 | 9,916,338 | 35.98 |
Alembic Pharmaceuticals Result Highlights
Alembic Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Alembic Pharmaceutic is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 5149.00 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2023. Alembic Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123.Market Cap | 15,058 |
Sales | 5,428 |
Shares in Float | 5.90 |
No of funds | 176 |
Yield | 1.03 |
Book Value | 3.44 |
U/D Vol ratio | 2.1 |
LTDebt / Equity | |
Alpha | 0.06 |
Beta | 0.82 |
Alembic Pharmaceuticals
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 69.61% | 69.61% | 69.61% | 69.61% |
Mutual Funds | 7.33% | 6.64% | 6.47% | 5.87% |
Insurance Companies | 6.57% | 6.74% | 6.55% | 6.6% |
Foreign Portfolio Investors | 4.51% | 4.34% | 4.55% | 4.99% |
Financial Institutions/ Banks | 0.03% | 0.03% | 0.04% | 0.04% |
Individual Investors | 8.24% | 8.98% | 9.08% | 9.21% |
Others | 3.71% | 3.66% | 3.7% | 3.68% |
Alembic Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Chirayu Amin | Chairman & CEO |
Mr. Pranav Amin | Managing Director |
Mr. Shaunak Amin | Managing Director |
Mr. R K Baheti | Director - Finance & CFO |
Mr. K G Ramanathan | Independent Director |
Mr. Pranav Parikh | Independent Director |
Mr. Paresh Saraiya | Independent Director |
Dr. Archana Hingorani | Independent Director |
Mr. Ashok Barat | Independent Director |
Mr. Jai Diwanji | Independent Director |
Alembic Pharmaceuticals Forecast
Price Estimates
Alembic Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-07 | Quarterly Results | |
2023-08-04 | Quarterly Results | |
2023-05-05 | Audited Results & Final Dividend | |
2023-02-01 | Quarterly Results | |
2022-11-11 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-07-28 | FINAL | Rs.8.00 per share(400%)Final Dividend |
2022-08-18 | INTERIM | Rs.10.00 per share(500%)Dividend (Changed Final Dividend as Interim Divided) |
Alembic Pharmaceuticals FAQs
What is Share Price of Alembic Pharmaceuticals ?
Alembic Pharmaceuticals share price is ₹765 As on 11 December, 2023 | 10:24
What is the Market Cap of Alembic Pharmaceuticals ?
The Market Cap of Alembic Pharmaceuticals is ₹15054.8 Cr As on 11 December, 2023 | 10:24
What is the P/E ratio of Alembic Pharmaceuticals ?
The P/E ratio of Alembic Pharmaceuticals is 28.3 As on 11 December, 2023 | 10:24
What is the PB ratio of Alembic Pharmaceuticals ?
The PB ratio of Alembic Pharmaceuticals is 3.4 As on 11 December, 2023 | 10:24